Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Microfilaments >> Actin etc >> Actin Binding Proteins
Anti-Vinculin antibody [hVIN-1]
See all Vinculin products (14) ...
Mouse monoclonal [hVIN-1] to Vinculin
Shows cross-reactivity with smooth muscle metavinculin.
ICC/IF, ICC, WB, IHC-Frmore details
Reacts with
Mouse, Rat, Chicken, Cow, Dog, Turkey, Human, Xenopus laevis
Predicted to work with
a wide range of other species
Full length native protein (purified) (Human).
cultured human fibroblasts
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 15mM Sodium Azide
Concentration information loading...
Ascites
Monoclonal
hVIN-1
IgG1
Cardiovascular >> Heart >> Contractility >> Contractile Proteins >> Actins
Cardiovascular >> Heart >> Cardiac arrhythmias
Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Microfilaments >> Actin etc >> Actin Binding Proteins
Our Abpromise guarantee covers the use of ab11194 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ICC/IF: 1/400((see Imamura et al). Fix with 3.5% formaldehyde solution in HMF (Hepes-buffered magnesium-free saline) for 15 min. Block with 1% BSA in PBS for 30min. Incubate with antibody for 30-60min.)
ICC: 1/400
WB: Use at an assay dependent dilution. Detects a band of approximately 116 kDa (predicted molecular weight: 123 kDa).
IHC-Fr: Use at an assay dependent dilution.
Actin filament (F-actin)-binding protein involved in cell-matrix adhesion and cell-cell adhesion. Regulates cell-surface E-cadherin expression and potentiates mechanosensing by the E-cadherin complex. May also play important roles in cell morphology and locomotion.
Metavinculin is muscle-specific.
Defects in VCL are the cause of cardiomyopathy dilated type 1W (CMD1W) [MIM:611407]. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.
Defects in VCL are the cause of cardiomyopathy familial hypertrophic type 15 (CMH15) [MIM:613255]. It is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.
Belongs to the vinculin/alpha-catenin family.
Exists in at least two conformations. When in the closed, 'inactive' conformation, extensive interactions between the head and tail domains prevent detectable binding to most of its ligands. It takes on an 'active' conformation after cooperative and simultaneous binding of two different ligands. This activation involves displacement of the head-tail interactions and leads to a significant accumulation of ternary complexes. The active form then binds a number of proteins that have both signaling and structural roles that are essential for cell adhesion.
The N-terminal globular head (Vh) comprises of subdomains D1-D4. The C-terminal tail (Vt) binds F-actin and cross-links actin filaments into bundles. An intramolecular interaction between Vh and Vt masks the F-actin-binding domain located in Vt. The binding of talin and alpha-actinin to the D1 subdomain of vinculin induces a helical bundle conversion of this subdomain, leading to the disruption of the intramolecular interaction and the exposure of the cryptic F-actin-binding domain of Vt. Vt inhibits actin filament barbed end elongation without affecting the critical concentration of actin assembly.
Phosphorylated; on serines, threonines and tyrosines. Phosphorylation on Tyr-1133 in activated platelets affects head-tail interactions and cell spreading but has no effect on actin binding nor on localization to focal adhesion plaques.
Aceylated; mainly by myristic acid but also small amount of palmitic acid.
Cytoplasm > cytoskeleton. Cell junction > adherens junction. Cell membrane. Cytoplasmic face of adhesion plaques. Recruitment to cell-cell junctions occurs in a myosin II-dependent manner. Interaction with CTNNB1 is necessary for its localization to the cell-cell junctions.
Target information above from: UniProt accessionP18206
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Immunocytochemistry/ Immunofluorescence - Anti-Vinculin antibody [hVIN-1] (ab11194)
![Immunocytochemistry/ Immunofluorescence - Anti-Vinculin antibody [hVIN-1] (ab11194)](/ps/datasheet/images/11/ab11194/Vinculin-Primary-antibodies-ab11194-38.jpg)
ab11194 staining Vinculin in HUVEC cells by Immunocytochemistry/ Immunofluorescence.Cells were fixed in formaldehyde, permeabilized using 0.2% Triton X-100, blocked with 1% BSA for 16 hours at 4°C, then incubated with ab11194 at a 1/400 dilution for 1 hour at 22°C. The secondary used was an Alexa-Fluor 488 conjugated goat anti-mouse IgG polyclonal used at 5µg/ml.
Image courtesy of an anonymous Abreview.
Immunocytochemistry/ Immunofluorescence - Vinculin antibody [hVIN-1] (ab11194)
![Immunocytochemistry/ Immunofluorescence - Vinculin antibody [hVIN-1] (ab11194)](/ps/datasheet/Images/11/ab11194/ab11194_2.jpg)
ICC/IF image of ab11194 stained human HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab11194, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue). This antibody also gave a positive IF result in Hek293, HepG2 and MCF7 cells.
Immunocytochemistry/ Immunofluorescence - Vinculin antibody [hVIN-1] (ab11194)
![Immunocytochemistry/ Immunofluorescence - Vinculin antibody [hVIN-1] (ab11194)](/ps/datasheet/images/11/ab11194/Vinculin-Primary-antibodies-ab11194-4.jpg)
ab11194 staining vinculin in rat smooth muscle cells isolated from mesenteric artery cells by immunocytochemistry/ immunofluorescence. Cells were PFA fixed and permeabilized in 0.3% Triton X-100 prior to blocking in 2% BSA for 30 minutes at 20°C. The primary antibody was diluted 1/300 and incubated with the sample for 14 hours at 4°C. Alexa fluor® 488 chicken polyclonal to mouse Ig, diluted 1/400, was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
This product has been referenced in:
See all 13 publications for this product
Publishing research using ab11194? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Immunocytochemistry/ Immunofluorescence - Anti-Vinculin antibody [hVIN-1] (ab11194)](/ps/datasheet/images/11/ab11194/Vinculin-Primary-antibodies-ab11194-38.jpg)
ab11194 staining Vinculin in HUVEC cells by Immunocytochemistry/ Immunofluorescence.Cells were fixed in formaldehyde, permeabilized using 0.2% Triton X-100, blocked with 1% BSA for 16 hours at 4°C, then incubated with ab11194 at a 1/400 dilution for 1 hour at 22°C. The secondary used was an Alexa-Fluor 488 conjugated goat anti-mouse IgG polyclonal used at 5µg/ml.
Image courtesy of an anonymous Abreview.
![Immunocytochemistry/ Immunofluorescence - Vinculin antibody [hVIN-1] (ab11194)](/ps/datasheet/Images/11/ab11194/ab11194_2.jpg)
ICC/IF image of ab11194 stained human HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab11194, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue). This antibody also gave a positive IF result in Hek293, HepG2 and MCF7 cells.
![Immunocytochemistry/ Immunofluorescence - Vinculin antibody [hVIN-1] (ab11194)](/ps/datasheet/images/11/ab11194/Vinculin-Primary-antibodies-ab11194-4.jpg)
ab11194 staining vinculin in rat smooth muscle cells isolated from mesenteric artery cells by immunocytochemistry/ immunofluorescence. Cells were PFA fixed and permeabilized in 0.3% Triton X-100 prior to blocking in 2% BSA for 30 minutes at 20°C. The primary antibody was diluted 1/300 and incubated with the sample for 14 hours at 4°C. Alexa fluor® 488 chicken polyclonal to mouse Ig, diluted 1/400, was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
4
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
